BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

954 related articles for article (PubMed ID: 15148559)

  • 21. Cellular and hormonal mechanisms associated with malignant bone resorption.
    Quinn JM; Matsumura Y; Tarin D; McGee JO; Athanasou NA
    Lab Invest; 1994 Oct; 71(4):465-71. PubMed ID: 7526033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteoclast deficiency results in disorganized matrix, reduced mineralization, and abnormal osteoblast behavior in developing bone.
    Dai XM; Zong XH; Akhter MP; Stanley ER
    J Bone Miner Res; 2004 Sep; 19(9):1441-51. PubMed ID: 15312244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parathyroid hormone temporal effects on bone formation and resorption.
    Kroll MH
    Bull Math Biol; 2000 Jan; 62(1):163-88. PubMed ID: 10824426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation and function of osteoclasts cultured on bone and cartilage.
    Suzumoto R; Takami M; Sasaki T
    J Electron Microsc (Tokyo); 2005 Dec; 54(6):529-40. PubMed ID: 16510510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early scanning electron microscopic studies of hard tissue resorption: their relation to current concepts reviewed.
    Boyde A; Jones SJ
    Scanning Microsc; 1987 Mar; 1(1):369-81. PubMed ID: 3589611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteoclast-derived activity in the coupling of bone formation to resorption.
    Martin TJ; Sims NA
    Trends Mol Med; 2005 Feb; 11(2):76-81. PubMed ID: 15694870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio.
    Seriwatanachai D; Thongchote K; Charoenphandhu N; Pandaranandaka J; Tudpor K; Teerapornpuntakit J; Suthiphongchai T; Krishnamra N
    Bone; 2008 Mar; 42(3):535-46. PubMed ID: 18166509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deposition of cement at reversal lines in rat femoral bone.
    Zhou H; Chernecky R; Davies JE
    J Bone Miner Res; 1994 Mar; 9(3):367-74. PubMed ID: 8191930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cells of the mononuclear phagocyte series differentiate into osteoclastic lacunar bone resorbing cells.
    Quinn JM; Sabokbar A; Athanasou NA
    J Pathol; 1996 May; 179(1):106-11. PubMed ID: 8691334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of lysyl hydroxylase-2b leads to defective collagen fibrillogenesis and matrix mineralization.
    Pornprasertsuk S; Duarte WR; Mochida Y; Yamauchi M
    J Bone Miner Res; 2005 Jan; 20(1):81-7. PubMed ID: 15619673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
    Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
    Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of multigrooved surfaces on osteoblast-like cells in vitro: scanning electron microscopic observation and mRNA expression of osteopontin and osteocalcin.
    Matsuzaka K; Yoshinari M; Shimono M; Inoue T
    J Biomed Mater Res A; 2004 Feb; 68(2):227-34. PubMed ID: 14704964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Morpho-functional correlations of the structure of bone cells and adjoining bone matrix in the developing bone].
    Doktorov AA; Denisov-Nikol'skiĭ IuI
    Arkh Anat Gistol Embriol; 1991 Jan; 100(1):68-74. PubMed ID: 2053868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracellular glutamate alters mature osteoclast and osteoblast functions.
    Seidlitz EP; Sharma MK; Singh G
    Can J Physiol Pharmacol; 2010 Sep; 88(9):929-36. PubMed ID: 20921979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in the ultrastructural assessment of osteoclastic resorptive functions.
    Sasaki T
    Microsc Res Tech; 1996 Feb; 33(2):182-91. PubMed ID: 8845517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of fibrillar structure of collagenous carrier in bone sialoprotein-mediated matrix mineralization and osteoblast differentiation.
    Xu L; Anderson AL; Lu Q; Wang J
    Biomaterials; 2007 Feb; 28(4):750-61. PubMed ID: 17045334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mineralization of bone-like extracellular matrix in the absence of functional osteoblasts.
    Marsh ME; Munne AM; Vogel JJ; Cui Y; Franceschi RT
    J Bone Miner Res; 1995 Nov; 10(11):1635-43. PubMed ID: 8592939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone structure and function.
    Buckwalter JA; Cooper RR
    Instr Course Lect; 1987; 36():27-48. PubMed ID: 3325555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage activation results in bone resorption.
    Lassus J; Salo J; Jiranek WA; Santavirta S; Nevalainen J; Matucci-Cerinic M; Horák P; Konttinen Y
    Clin Orthop Relat Res; 1998 Jul; (352):7-15. PubMed ID: 9678028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Azanitrile Cathepsin K Inhibitors: Effects on Cell Toxicity, Osteoblast-Induced Mineralization and Osteoclast-Mediated Bone Resorption.
    Ren ZY; Machuca-Gayet I; Domenget C; Buchet R; Wu Y; Jurdic P; Mebarek S
    PLoS One; 2015; 10(7):e0132513. PubMed ID: 26168340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.